 |
MorphoSys AG
MOR
|
1.75 |
- |
2.43 % |
$ 254 M |
Germany |
 |
Acorda Therapeutics
ACOR
|
0.142 |
- |
-24.86 % |
$ 820 K |
USA |
 |
Adverum Biotechnologies
ADVM
|
76.4 |
- |
- |
$ 86.2 M |
USA |
 |
Alnylam Pharmaceuticals
ALNY
|
11 |
$ 332.9 |
-1.92 % |
$ 43.6 B |
USA |
 |
I-Mab
IMAB
|
94.1 |
- |
- |
$ 866 M |
China |
 |
Alterity Therapeutics Limited
ATHE
|
131 |
$ 3.69 |
1.93 % |
$ 8.88 B |
Australia |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 |
- |
- |
$ 40.3 B |
USA |
 |
Genfit SA
GNFT
|
1.96 K |
- |
2.54 % |
$ 160 B |
France |
 |
Aligos Therapeutics
ALGS
|
30.2 |
$ 7.5 |
-14.24 % |
$ 74.1 M |
USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K |
- |
-1.52 % |
$ 24.7 M |
USA |
 |
Burford Capital Limited
BUR
|
6.35 |
$ 4.75 |
0.74 % |
$ 761 M |
Britain |
 |
Cabaletta Bio
CABA
|
50.3 M |
$ 3.37 |
3.22 % |
$ 339 M |
USA |
 |
Midatech Pharma plc
MTP
|
137 |
- |
-18.52 % |
$ 27.3 M |
Britain |
 |
Applied Therapeutics
APLT
|
54.1 |
- |
- |
$ 8.42 M |
USA |
 |
Aptinyx
APTX
|
204 |
- |
-39.0 % |
$ 4.57 M |
USA |
 |
Aravive
ARAV
|
6.61 |
- |
-13.39 % |
$ 1.45 M |
USA |
 |
Amphastar Pharmaceuticals
AMPH
|
1.73 |
$ 21.31 |
-0.33 % |
$ 996 M |
USA |
 |
BioNTech SE
BNTX
|
35.7 |
$ 99.6 |
1.21 % |
$ 27.2 B |
Germany |
 |
Can-Fite BioPharma Ltd.
CANF
|
759 |
$ 3.04 |
-0.33 % |
$ 5 M |
Israel |
 |
Институт стволовых клеток человека
ISKJ
|
2.61 |
- |
- |
- |
Russia |
 |
Advaxis
ADXS
|
144 |
- |
-9.65 % |
$ 45.9 M |
USA |
 |
Aeterna Zentaris
AEZS
|
7.87 |
- |
5.93 % |
$ 314 M |
Canada |
 |
AgeX Therapeutics
AGE
|
0.099 |
- |
-10.17 % |
$ 12.2 K |
USA |
 |
Aeglea BioTherapeutics
AGLE
|
489 |
- |
- |
$ 1.01 B |
USA |
 |
Akebia Therapeutics
AKBA
|
1.42 |
$ 1.54 |
-1.28 % |
$ 396 M |
USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
65.5 |
- |
- |
$ 26.5 M |
USA |
 |
Aquestive Therapeutics
AQST
|
10.5 |
$ 4.16 |
0.12 % |
$ 445 M |
USA |
 |
Arcutis Biotherapeutics
ARQT
|
9.15 |
$ 24.45 |
-2.55 % |
$ 3.11 B |
USA |
 |
BioDelivery Sciences International
BDSI
|
1.85 |
- |
-4.8 % |
$ 255 M |
USA |
 |
Autolus Therapeutics plc
AUTL
|
4.27 |
$ 1.47 |
-1.01 % |
$ 391 M |
Britain |
 |
BeiGene, Ltd.
BGNE
|
66.4 |
- |
0.49 % |
$ 251 B |
Cayman-islands |
 |
Ayala Pharmaceuticals
AYLA
|
11.2 |
- |
- |
$ 7.46 M |
Israel |
 |
bluebird bio
BLUE
|
2.27 |
- |
- |
$ 546 M |
USA |
 |
AstraZeneca PLC
AZN
|
2.17 |
- |
- |
$ 96.9 B |
Britain |
 |
CureVac N.V.
CVAC
|
281 |
- |
- |
$ 867 M |
Germany |
 |
Cidara Therapeutics
CDTX
|
116 |
- |
- |
$ 1.41 B |
USA |
 |
Baudax Bio
BXRX
|
0.614 |
- |
0.59 % |
$ 63 K |
USA |